Bristol Myers Squibb· @bmsnews · X·· 25 天前AI 评分29
AI 导读
#MEDIA: 在#ESMO26上公布评估我们针对部分HR+/HER2-乳腺癌成人患者的研究性治疗的III期试验结果。https://bit.ly/4siOO3r
正文
#MEDIA: Announcing results from a Phase 3 trial evaluating our investigational treatment for certain adult patients with HR+/HER2- breast cancer at #ESMO26. https://bit.ly/4siOO3r
来源:Bristol Myers Squibb · x.com